Prof. Giorgi Pkhakadze
Intermittent Fasting Rewires Brain and Gut Microbiome, New Study Reveals
New research reveals intermittent fasting triggers coordinated changes in brain appetite control regions and gut microbiome composition. The findings suggest…
MAGE-A4/MAGE-A8-Targeted Bispecific T Cell Engager Shows Promise in Refractory Solid Tumors
Novel bispecific T cell engager IMA401 targeting MAGE-A4/MAGE-A8 shows encouraging safety and preliminary efficacy in phase 1a trial. Early results…
Triple-Drug Therapy Extends Survival in Advanced Prostate Cancer Trial
Triple-drug combination therapy significantly improved survival outcomes in advanced prostate cancer trial. The approach combines PARP inhibition with androgen-signaling blockers…
Sleep Quality Emerges as Critical Factor in Trauma Recovery for Forced Migrants
New research reveals sleep quality significantly affects mental health, pain, and cardiovascular recovery in forced migrants. The study supports holistic…
Multi-country study reveals critical gaps in Chagas disease data systems across Bolivia and Paraguay
New research identifies critical gaps in Chagas disease surveillance systems across Bolivia and Paraguay. The multi-level study offers actionable guidance…
UK approves 342 parallel drug import licences in 2026 amid post-Brexit medicine access challenges
UK regulators approved 342 parallel import licences for medicines in 2026, a 15% increase reflecting growing reliance on EU supply…
UK Approves 47 New Medicines in 2026, Including Breakthrough Alzheimer’s Treatment
The UK approved 47 new medicines in 2026, with neurological treatments leading the way. The MHRA's accelerated pathways reduced approval…
Scientists Reverse Anxiety in Mice by Targeting Tiny Amygdala Circuit
Researchers successfully reversed anxiety in mice by targeting a specific group of amygdala neurons. The breakthrough identifies a promising new…